The present study is the first to identify that ilimaquinone and ethylsmenoquinone from a marine sponge drive the accumulation of the p53 protein, thereby activating the p53 signaling pathway and efficiently inhibiting the growth of human colon cancer cells in the absence of TRAIL. Here, TP53 is linked to colonic neoplasm.